{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:50:14Z","timestamp":1791557414875,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jaad.2016.08.061","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T11:32:24Z","timestamp":1478086344000},"page":"368-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review"],"prefix":"10.1016","volume":"76","author":[{"given":"Xiaomei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1875-1692","authenticated-orcid":false,"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urb\u00e0","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siliang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.08.061_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjd.13196","article-title":"British Association of Dermatologists' guidelines for the management of tinea capitis 2014","volume":"171","author":"Fuller","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1439-0507.2007.01424.x","article-title":"Epidemiology of tinea capitis in Europe: current state and changing patterns","volume":"50","author":"Ginter-Hanselmayer","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2016.08.061_bib3","first-page":"525","article-title":"Tinea capitis: a review","volume":"19","author":"Sarabi","year":"2007","journal-title":"Dermatol Nurs"},{"issue":"5","key":"10.1016\/j.jaad.2016.08.061_bib4","first-page":"CD004685","article-title":"Systemic antifungal therapy for tinea capitis in children","author":"Chen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2016.08.061_bib5","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed June 23, 2016."},{"key":"10.1016\/j.jaad.2016.08.061_bib6","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014."},{"key":"10.1016\/j.jaad.2016.08.061_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0190-9622(00)90013-6","article-title":"Comparison of terbinafine and griseofulvin in the treatment of tinea capitis","volume":"42","author":"C\u00e1ceres-R\u00edos","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09546630510025932","article-title":"Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole","volume":"16","author":"Dastghaib","year":"2005","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.jaad.2016.08.061_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11046-011-9438-2","article-title":"A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China","volume":"172","author":"Deng","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jaad.2016.08.061_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2008.02.019","article-title":"Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials","volume":"59","author":"Elewski","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1468-3083.1998.tb00767.x","article-title":"Efficacy, safety and tolerability of terbinafine for tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1, 2 and 4 weeks","volume":"11","author":"Filho","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.08.061_bib12","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jaad.2005.07.028","article-title":"A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis","volume":"53","author":"Foster","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1542\/peds.109.4.602","article-title":"Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study","volume":"109","author":"Friedlander","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2016.08.061_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2133.2001.04022.x","article-title":"A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis","volume":"144","author":"Fuller","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00006454-198701000-00012","article-title":"Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin","volume":"6","author":"Gan","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2016.08.061_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1525-1470.2001.01978.x","article-title":"Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole","volume":"18","author":"Gupta","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2133.1999.02713.x","article-title":"Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The study group","volume":"140","author":"Hamm","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2133.1996.tb03613.x","article-title":"A randomized double-blind comparative study of terbinafine for 1, 2, and 4 weeks in tinea capitis","volume":"135","author":"Haroon","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/09546639509097176","article-title":"A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis","volume":"6","author":"Haroon","year":"1995","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2016.08.061_bib20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2133.1998.02465.x","article-title":"A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis","volume":"139","author":"Jahangir","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib21","first-page":"281","article-title":"Efficacy of terbinafine vs. griseofulvin in tinea capitis in the northern areas of Pakistan","volume":"21","author":"Khan","year":"2011","journal-title":"JPAD"},{"key":"10.1016\/j.jaad.2016.08.061_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0190-9622(97)80140-5","article-title":"Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis","volume":"37","author":"Kullavanijaya","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2002.04744.x","article-title":"A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species","volume":"146","author":"Lipozencic","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-4362.1994.tb01525.x","article-title":"Itraconazole versus\u00a0griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children","volume":"33","author":"L\u00f3pez-G\u00f3mez","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00006454-198801000-00009","article-title":"Double-blind study of ketoconazole and griseofulvin in dermatophytoses","volume":"7","author":"Mart\u00ednez-Roig","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2016.08.061_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/09546639909056027","article-title":"Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis","volume":"10","author":"Memisoglu","year":"1999","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2016.08.061_bib27","first-page":"55","article-title":"Griseofulvin and terbinafine in the treatment of tinea capitis in children","volume":"111","author":"Rademaker","year":"1998","journal-title":"N Z Med J"},{"key":"10.1016\/j.jaad.2016.08.061_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0190-9622(97)80141-7","article-title":"Fluconazole for the treatment of tinea capitis in children","volume":"37","author":"Solomon","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3476(88)80232-4","article-title":"Treating tinea capitis: Should ketoconazole replace griseofulvin?","volume":"112","author":"Tanz","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2016.08.061_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00006565-198503000-00005","article-title":"Comparison of ketoconazole and griseofulvin for treatment of tinea capitis in childhood: a preliminary study","volume":"1","author":"Tanz","year":"1985","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jaad.2016.08.061_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2230.2004.01493.x","article-title":"Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine","volume":"29","author":"Ungpakorn","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib32","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. Available at: http:\/\/www.guidelinedevelopment.org\/handbook. Accessed June 23, 2016."},{"key":"10.1016\/j.jaad.2016.08.061_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(00)90001-X","article-title":"Tinea capitis: a current perspective","volume":"42","author":"Elewski","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.08.061_bib34","unstructured":"U.S. Food and Drug Administration. Nizoral (ketoconazole) oral tablets: drug safety communication\u2013prescribing for unapproved uses including skin and nail infections continues; linked to patient death. FDA medwatch. Available at: http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/safetyalertsforhumanmedicalproducts\/ucm502073.htm. Accessed August 6, 2016."},{"key":"10.1016\/j.jaad.2016.08.061_bib35","unstructured":"Health Canada. Public communication\u2013Health Canada endorsed important safety information on ketoconazole. Available at: http:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2013\/34177a-eng.php. Accessed August 6, 2016."},{"key":"10.1016\/j.jaad.2016.08.061_bib36","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216307496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216307496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:41:10Z","timestamp":1759272070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216307496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0190962216307496"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.08.061","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}